Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
2,4,6-trichlorophenol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00962
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Fungicide |
DME Modulation |
2,4,6-trichlorophenol inhibits the expression of DME HSD3B1 |
[1] |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Pentachlorophenol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01605
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Pentachlorophenol inhibits the expression of DME HSD3B1 |
[2] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Fipronil |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01302
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Fipronil inhibits the expression of DME HSD3B1 |
[3] |
Formaldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde up-regulates the expression of DME HSD3B1 |
[4] |
Ochratoxin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01407
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Ochratoxin A induces the drug-metabolizing activity of DME HSD3B1 |
[5] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 inhibits the expression of DME HSD3B1 |
[6] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME HSD3B1 |
[7] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
Calcitriol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Calcitriol up-regulates the expression of DME HSD3B1 |
[8] |
Diethylstilbestrol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00166
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Diethylstilbestrol inhibits the expression of DME HSD3B1 |
[9] |
Estradiol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol up-regulates the expression of DME HSD3B1 |
[9] |
Isotretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00186
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Isotretinoin inhibits the expression of DME HSD3B1 |
[10] |
Mitotane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00064
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Mitotane inhibits the drug-metabolizing activity of DME HSD3B1 |
[11] |
Testosterone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00095
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Testosterone inhibits the expression of DME HSD3B1 |
[12] |
Arbutin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00461
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Arbutin inhibits the expression of DME HSD3B1 |
[13] |
Nadide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01390
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Nadide up-regulates the expression of DME HSD3B1 |
[14] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethyltoluamide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Diethyltoluamide inhibits the expression of DME HSD3B1 |
[3] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME HSD3B1 |
[15] |
Sulindac sulfide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00656
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Sulindac sulfide inhibits the drug-metabolizing activity of DME HSD3B1 |
[16] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Go-6976 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01321
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Go-6976 up-regulates the expression of DME HSD3B1 |
[17] |
SB-431542 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01147
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
SB-431542 up-regulates the expression of DME HSD3B1 |
[18] |
|
|
|
|
|
|